nad+ and tirzepatide With Combination Guide Peptide Therapy in Memphis, TN

For mild cold symptoms without gastrointestinal involvement, most people can safely continue their GLP-1 medication

A 2023 review in the Journal of Clinical Endocrinology & Metabolism highlighted that GLP-1s can delay gastric emptying significantly, especially at higher doses or early in treatment.44 Another study found that just over 5% of patients experience gastroparesis and it was more likely when using liraglutide or dulaglutide when compared with semaglutide.45 A 2024 cross-sectional analysis in Pharmaceuticals examined the GI side effects of semaglutide, dulaglutide, liraglutide, and exenatide in over 10,000 adults with T2DM or obesity from the National Institutes of Health All of Us cohort.45 They found that abdominal pain was the most frequently reported GI issue (57.6%), followed by constipation, diarrhea, nausea/vomiting, GI bleeding, gastroparesis, and pancreatitis

Our platform offers tailored plans based on individual needs and goals

Araki E, Inagaki N, Tanizawa Y, Oura T, Takeuchi M, Imaoka T

Monitoring how your body reacts to different foods and maintaining regular check-ins with your provider is crucial

For example, medications like Wegovy and Ozempic are available at reduced prices through manufacturer savings programs offered by Novo Nordisk